Novavax Inc. Stock Advances 7.0%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. advanced 7.0% to $10.00 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.7% to 26,418.30 and the Dow Jones Industrial Average rising 0.6% to 51,778.04.

This was the stock's second consecutive day of gains.

Novavax Inc. closed 16.5% short of its 52-week high of $11.97, which the company achieved on February 26th.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.22, Pfizer Inc. rose 0.7% to $27.64, and Merck & Co. Inc. rose 1.55% to $147.15.

Trading volume totaled 8.9 million, compared to the 50-day average of 4.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 17, 2026 16:33 ET (20:33 GMT)